SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40FR12B - Registration of a Class of Securities of certain Canadian issuers [Section 12(b)]:
SEC Accession No. 0001193125-14-145986
Filing Date
2014-04-16
Accepted
2014-04-16 17:01:10
Documents
7

Document Format Files

Seq Description Document Type Size
1 40FR12B d710955d40fr12b.htm 40FR12B 21222
2 EX-99.1 d710955dex991.htm EX-99.1 317264
3 EX-99.2 d710955dex992.htm EX-99.2 253952
4 EX-99.3 d710955dex993.htm EX-99.3 559184
5 GRAPHIC g710955ex99_1covs1gbgd.jpg GRAPHIC 28543
6 GRAPHIC g710955ex99_2covs1gbgd.jpg GRAPHIC 30154
7 GRAPHIC g710955ex99_3covs1gbgd.jpg GRAPHIC 30029
  Complete submission text file 0001193125-14-145986.txt   1275240
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 40FR12B | Act: 34 | File No.: 001-36421 | Film No.: 14767970